-
IBBQ Dashboard
- Holdings
Invesco Nasdaq Biotechnology ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
Invesco Private Prime Fund | 7.37 mm | 7.37 mm shares | 19.20 | Short-term investment vehicle | Long | USA |
GILD Gilead Sciences, Inc. | 3.41 mm | 43.16 k shares | 8.88 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 3.35 mm | 2.83 k shares | 8.73 | Common equity | Long | USA |
AMGN Amgen Inc. | 3.03 mm | 9.07 k shares | 7.89 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 3.02 mm | 6.09 k shares | 7.87 | Common equity | Long | USA |
Invesco Private Government Fund | 2.87 mm | 2.87 mm shares | 7.48 | Short-term investment vehicle | Long | USA |
AstraZeneca PLC, ADR
|
1.56 mm | 17.78 k shares | 4.06 | Common equity | Long | UK |
ALNY Alnylam Pharmaceuticals, Inc. | 1.24 mm | 4.73 k shares | 3.24 | Common equity | Long | USA |
BIIB Biogen Inc. | 1.12 mm | 5.45 k shares | 2.91 | Common equity | Long | USA |
MRNA Moderna, Inc. | 1.09 mm | 14.13 k shares | 2.85 | Common equity | Long | USA |
ILMN Illumina, Inc. | 783.14 k | 5.96 k shares | 2.04 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 648.14 k | 7.11 k shares | 1.69 | Common equity | Long | USA |
ARGX argenx SE | 620.78 k | 1.20 k shares | 1.62 | Common equity | Long | Netherlands |
UTHR United Therapeutics Corporation | 604.58 k | 1.66 k shares | 1.58 | Common equity | Long | USA |
SNY Sanofi | 593.26 k | 10.55 k shares | 1.55 | Common equity | Long | France |
INCY Incyte Corporation | 552.92 k | 8.42 k shares | 1.44 | Common equity | Long | USA |
VTRS Viatris Inc. | 538.68 k | 44.59 k shares | 1.40 | Common equity | Long | USA |
RPRX Royalty Pharma plc | 490.75 k | 16.91 k shares | 1.28 | Common equity | Long | UK |
SRPT Sarepta Therapeutics, Inc. | 480.93 k | 3.54 k shares | 1.25 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 478.76 k | 3.77 k shares | 1.25 | Common equity | Long | USA |
INSM Insmed Incorporated | 461.96 k | 6.04 k shares | 1.20 | Common equity | Long | USA |
MEDP Medpace Holdings, Inc. | 411.76 k | 1.16 k shares | 1.07 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 341.80 k | 26.33 k shares | 0.89 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd. | 338.83 k | 27.71 k shares | 0.88 | Common equity | Long | Bermuda |
PCVX Vaxcyte, Inc. | 327.32 k | 4.05 k shares | 0.85 | Common equity | Long | USA |
BNTX BioNTech SE | 324.12 k | 3.67 k shares | 0.84 | Common equity | Long | Germany |
BGNE BeiGene, Ltd. | 307.23 k | 1.60 k shares | 0.80 | Common equity | Long | Cayman Islands |
HALO Halozyme Therapeutics, Inc. | 304.63 k | 4.77 k shares | 0.79 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 298.91 k | 2.16 k shares | 0.78 | Common equity | Long | Denmark |
ITCI Intra-Cellular Therapies, Inc. | 290.19 k | 3.96 k shares | 0.76 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 282.30 k | 10.85 k shares | 0.74 | Common equity | Long | USA |
JAZZ Jazz Pharmaceuticals plc | 272.32 k | 2.35 k shares | 0.71 | Common equity | Long | Ireland |
RVMD Revolution Medicines, Inc. | 261.83 k | 6.14 k shares | 0.68 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 259.28 k | 5.44 k shares | 0.68 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 243.56 k | 4.27 k shares | 0.63 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 222.89 k | 2.33 k shares | 0.58 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 208.00 k | 1.07 k shares | 0.54 | Common equity | Long | USA |
Madrigal Pharmaceuticals, Inc. | 195.97 k | 793.00 shares | 0.51 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 193.92 k | 6.96 k shares | 0.51 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 187.37 k | 2.20 k shares | 0.49 | Common equity | Long | USA |
ALKS Alkermes plc | 179.21 k | 6.30 k shares | 0.47 | Common equity | Long | Ireland |
RARE Ultragenyx Pharmaceutical Inc. | 175.90 k | 3.10 k shares | 0.46 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 175.87 k | 4.52 k shares | 0.46 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 174.84 k | 3.04 k shares | 0.46 | Common equity | Long | Cayman Islands |
IMVT Immunovant, Inc. | 168.16 k | 5.44 k shares | 0.44 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 167.86 k | 3.64 k shares | 0.44 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 156.93 k | 1.77 k shares | 0.41 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 156.82 k | 3.56 k shares | 0.41 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 155.94 k | 2.94 k shares | 0.41 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 150.80 k | 3.16 k shares | 0.39 | Common equity | Long | Switzerland |
ADMA ADMA Biologics, Inc. | 149.40 k | 8.63 k shares | 0.39 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 137.14 k | 2.00 k shares | 0.36 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 129.80 k | 5.31 k shares | 0.34 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 128.01 k | 11.03 k shares | 0.33 | Common equity | Long | USA |
MRUS Merus N.V. | 125.89 k | 2.47 k shares | 0.33 | Common equity | Long | Netherlands |
IOVA Iovance Biotherapeutics, Inc. | 121.44 k | 10.42 k shares | 0.32 | Common equity | Long | USA |
GH Guardant Health, Inc. | 116.54 k | 4.56 k shares | 0.30 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 115.24 k | 2.76 k shares | 0.30 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 113.40 k | 2.81 k shares | 0.30 | Common equity | Long | Canada |
IDYA IDEAYA Biosciences, Inc. | 111.31 k | 2.82 k shares | 0.29 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 110.70 k | 2.29 k shares | 0.29 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 110.09 k | 4.62 k shares | 0.29 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 107.16 k | 2.27 k shares | 0.28 | Common equity | Long | USA |
GERN Geron Corporation | 104.91 k | 22.09 k shares | 0.27 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 101.97 k | 6.15 k shares | 0.27 | Common equity | Long | USA |
IBRX ImmunityBio, Inc. | 101.71 k | 25.75 k shares | 0.26 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 100.80 k | 2.85 k shares | 0.26 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 96.82 k | 2.11 k shares | 0.25 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 95.33 k | 3.37 k shares | 0.25 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 93.83 k | 2.17 k shares | 0.24 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 93.71 k | 2.19 k shares | 0.24 | Common equity | Long | USA |
VCEL Vericel Corporation | 93.69 k | 1.81 k shares | 0.24 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 90.58 k | 1.93 k shares | 0.24 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 89.76 k | 2.85 k shares | 0.23 | Common equity | Long | USA |
AMPH Amphastar Pharmaceuticals, Inc. | 88.95 k | 1.83 k shares | 0.23 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 85.86 k | 1.68 k shares | 0.22 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 81.88 k | 3.07 k shares | 0.21 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 80.63 k | 3.59 k shares | 0.21 | Common equity | Long | USA |
NVCR NovoCure Limited | 77.97 k | 4.01 k shares | 0.20 | Common equity | Long | Jersey |
VERA Vera Therapeutics, Inc. | 77.04 k | 2.04 k shares | 0.20 | Common equity | Long | USA |
FTRE Fortrea Holdings Inc. | 76.72 k | 3.33 k shares | 0.20 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings, Inc. | 75.92 k | 2.11 k shares | 0.20 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 75.57 k | 1.75 k shares | 0.20 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals, Inc. | 71.94 k | 2.05 k shares | 0.19 | Common equity | Long | USA |
VRNA Verona Pharma plc | 71.45 k | 2.60 k shares | 0.19 | Common equity | Long | UK |
LGND Ligand Pharmaceuticals Incorporated | 70.46 k | 666.00 shares | 0.18 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 69.93 k | 2.57 k shares | 0.18 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 69.66 k | 1.83 k shares | 0.18 | Common equity | Long | Cayman Islands |
BCRX BioCryst Pharmaceuticals, Inc. | 66.77 k | 7.68 k shares | 0.17 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 66.60 k | 2.55 k shares | 0.17 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 65.18 k | 3.48 k shares | 0.17 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 65.00 k | 3.16 k shares | 0.17 | Common equity | Long | USA |
NVAX Novavax, Inc. | 64.69 k | 5.23 k shares | 0.17 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 63.81 k | 3.39 k shares | 0.17 | Common equity | Long | USA |
MNKD MannKind Corporation | 63.50 k | 10.14 k shares | 0.17 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 62.45 k | 8.58 k shares | 0.16 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 61.13 k | 1.35 k shares | 0.16 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 59.73 k | 2.84 k shares | 0.16 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 55.64 k | 2.21 k shares | 0.14 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 54.68 k | 4.87 k shares | 0.14 | Common equity | Long | USA |
AVDL Avadel Pharmaceuticals plc | 54.32 k | 3.58 k shares | 0.14 | Common equity | Long | Ireland |
ARDX Ardelyx, Inc. | 53.81 k | 8.71 k shares | 0.14 | Common equity | Long | USA |
HROW Harrow Health, Inc. | 53.12 k | 1.31 k shares | 0.14 | Common equity | Long | USA |
OCUL Ocular Therapeutix, Inc. | 50.89 k | 5.77 k shares | 0.13 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 49.92 k | 8.25 k shares | 0.13 | Common equity | Long | USA |
IMCR Immunocore Holdings plc | 49.87 k | 1.39 k shares | 0.13 | Common equity | Long | UK |
ANIP ANI Pharmaceuticals, Inc. | 49.79 k | 781.00 shares | 0.13 | Common equity | Long | USA |
TNGX Tango Therapeutics, Inc. | 47.02 k | 3.98 k shares | 0.12 | Common equity | Long | USA |
COLL Collegium Pharmaceutical, Inc. | 46.92 k | 1.22 k shares | 0.12 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 46.86 k | 922.00 shares | 0.12 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 46.85 k | 4.31 k shares | 0.12 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 46.83 k | 3.61 k shares | 0.12 | Common equity | Long | USA |
INVA Innoviva, Inc. | 45.10 k | 2.33 k shares | 0.12 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 45.06 k | 3.26 k shares | 0.12 | Common equity | Long | USA |
MRVI Maravai LifeSciences Holdings, Inc. | 44.81 k | 4.95 k shares | 0.12 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 44.65 k | 2.01 k shares | 0.12 | Common equity | Long | Ireland |
Genmab A/S, ADR
|
43.42 k | 1.56 k shares | 0.11 | Common equity | Long | Denmark |
GRFS Grifols, S.A. | 42.43 k | 4.54 k shares | 0.11 | Common equity | Long | Spain |
CGEM Cullinan Oncology, Inc. | 42.12 k | 2.15 k shares | 0.11 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 41.82 k | 5.06 k shares | 0.11 | Common equity | Long | USA |
KNSA Kiniksa Pharmaceuticals, Ltd. | 40.24 k | 1.51 k shares | 0.10 | Common equity | Long | UK |
XNCR Xencor, Inc. | 40.23 k | 2.30 k shares | 0.10 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 38.55 k | 1.01 k shares | 0.10 | Common equity | Long | USA |
ELVN Enliven Therapeutics, Inc. | 38.29 k | 1.75 k shares | 0.10 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 38.27 k | 3.56 k shares | 0.10 | Common equity | Long | USA |
Zai Lab Ltd., ADR
|
38.17 k | 1.91 k shares | 0.10 | Common equity | Long | Cayman Islands |
TARS Tarsus Pharmaceuticals, Inc. | 38.14 k | 1.41 k shares | 0.10 | Common equity | Long | USA |
EOLS Evolus, Inc. | 37.07 k | 2.33 k shares | 0.10 | Common equity | Long | USA |
AUPH Aurinia Pharmaceuticals Inc. | 36.27 k | 5.33 k shares | 0.09 | Common equity | Long | Canada |
PHAT Phathom Pharmaceuticals, Inc. | 36.03 k | 2.18 k shares | 0.09 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 34.77 k | 3.66 k shares | 0.09 | Common equity | Long | USA |
PETQ PetIQ, Inc. | 33.57 k | 1.10 k shares | 0.09 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 33.52 k | 4.94 k shares | 0.09 | Common equity | Long | USA |
ZYME Zymeworks Inc. | 30.91 k | 2.64 k shares | 0.08 | Common equity | Long | USA |
CSTL Castle Biosciences, Inc. | 30.62 k | 1.03 k shares | 0.08 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals, Inc. | 29.96 k | 5.92 k shares | 0.08 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 29.81 k | 2.24 k shares | 0.08 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 29.18 k | 7.42 k shares | 0.08 | Common equity | Long | UK |
CNTA Centessa Pharmaceuticals plc | 29.16 k | 2.16 k shares | 0.08 | Common equity | Long | UK |
BCYC Bicycle Therapeutics plc | 28.85 k | 1.34 k shares | 0.08 | Common equity | Long | UK |
FDMT 4D Molecular Therapeutics, Inc. | 28.85 k | 1.92 k shares | 0.08 | Common equity | Long | USA |
ABCL AbCellera Biologics Inc. | 28.03 k | 10.95 k shares | 0.07 | Common equity | Long | Canada |
ERAS Erasca, Inc. | 27.97 k | 9.68 k shares | 0.07 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 27.62 k | 2.97 k shares | 0.07 | Common equity | Long | USA |
ABUS Arbutus Biopharma Corporation | 27.20 k | 7.03 k shares | 0.07 | Common equity | Long | Canada |
PCRX Pacira BioSciences, Inc. | 26.97 k | 1.73 k shares | 0.07 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 26.84 k | 2.83 k shares | 0.07 | Common equity | Long | USA |
HUMA Humacyte, Inc. | 26.81 k | 4.43 k shares | 0.07 | Common equity | Long | USA |
CVAC CureVac N.V. | 26.22 k | 8.35 k shares | 0.07 | Common equity | Long | Netherlands |
WVE Wave Life Sciences Ltd. | 26.17 k | 4.56 k shares | 0.07 | Common equity | Long | Singapore |
ORIC ORIC Pharmaceuticals, Inc. | 26.03 k | 2.51 k shares | 0.07 | Common equity | Long | USA |
ADPT Adaptive Biotechnologies Corporation | 25.79 k | 5.49 k shares | 0.07 | Common equity | Long | USA |
RVNC Revance Therapeutics, Inc. | 25.56 k | 3.89 k shares | 0.07 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals, Inc. | 24.54 k | 2.08 k shares | 0.06 | Common equity | Long | USA |
SIGA SIGA Technologies, Inc. | 23.92 k | 2.65 k shares | 0.06 | Common equity | Long | USA |
ITOS iTeos Therapeutics, Inc. | 23.40 k | 1.39 k shares | 0.06 | Common equity | Long | USA |
YMAB Y-mAbs Therapeutics, Inc. | 23.33 k | 1.63 k shares | 0.06 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 23.30 k | 2.29 k shares | 0.06 | Common equity | Long | USA |
LXRX Lexicon Pharmaceuticals, Inc. | 23.29 k | 13.46 k shares | 0.06 | Common equity | Long | USA |
MLYS Mineralys Therapeutics, Inc. | 22.97 k | 1.85 k shares | 0.06 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 22.45 k | 1.84 k shares | 0.06 | Common equity | Long | USA |
Galapagos N.V., ADR
|
22.10 k | 759.00 shares | 0.06 | Common equity | Long | Belgium |
SVRA Savara Inc. | 21.98 k | 5.15 k shares | 0.06 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 21.08 k | 999.00 shares | 0.05 | Common equity | Long | USA |
KALV KalVista Pharmaceuticals, Inc. | 21.04 k | 1.57 k shares | 0.05 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 20.95 k | 3.13 k shares | 0.05 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 20.46 k | 7.78 k shares | 0.05 | Common equity | Long | USA |
HCM HUTCHMED (China) Limited | 20.08 k | 1.15 k shares | 0.05 | Common equity | Long | Cayman Islands |
FULC Fulcrum Therapeutics, Inc. | 19.81 k | 2.32 k shares | 0.05 | Common equity | Long | USA |
PRME Prime Medicine, Inc. | 19.11 k | 4.46 k shares | 0.05 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corp. | 18.97 k | 3.15 k shares | 0.05 | Common equity | Long | USA |
ALEC Alector, Inc. | 18.96 k | 3.59 k shares | 0.05 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 18.87 k | 2.24 k shares | 0.05 | Common equity | Long | USA |
URGN UroGen Pharma Ltd. | 18.78 k | 1.35 k shares | 0.05 | Common equity | Long | Israel |
OABI OmniAb, Inc. | 18.35 k | 4.38 k shares | 0.05 | Common equity | Long | USA |
TERN Terns Pharmaceuticals, Inc. | 18.33 k | 2.40 k shares | 0.05 | Common equity | Long | USA |
EYPT EyePoint Pharmaceuticals, Inc. | 17.65 k | 1.97 k shares | 0.05 | Common equity | Long | USA |
THRD Third Harmonic Bio, Inc. | 17.65 k | 1.53 k shares | 0.05 | Common equity | Long | USA |
SLRN Acelyrin, Inc. | 17.60 k | 3.68 k shares | 0.05 | Common equity | Long | USA |
MXCT MaxCyte, Inc. | 16.83 k | 3.90 k shares | 0.04 | Common equity | Long | USA |
TRML Tourmaline Bio, Inc. | 16.07 k | 954.00 shares | 0.04 | Common equity | Long | USA |
PAHC Phibro Animal Health Corporation | 15.94 k | 759.00 shares | 0.04 | Common equity | Long | USA |
TSHA Taysha Gene Therapies, Inc. | 15.59 k | 6.96 k shares | 0.04 | Common equity | Long | USA |
XERS Xeris Pharmaceuticals Inc | 15.51 k | 5.52 k shares | 0.04 | Common equity | Long | USA |
TBPH Theravance Biopharma, Inc. | 14.97 k | 1.82 k shares | 0.04 | Common equity | Long | Cayman Islands |
CFRXQ ContraFect Corporation | 13.90 k | 10.15 k shares | 0.04 | Common equity | Long | USA |
GRAL GRAIL, LLC | 13.90 k | 985.00 shares | 0.04 | Common equity | Long | USA |
LYEL Lyell Immunopharma, Inc. | 13.76 k | 9.49 k shares | 0.04 | Common equity | Long | USA |
VYGR Voyager Therapeutics, Inc. | 13.29 k | 2.03 k shares | 0.03 | Common equity | Long | USA |
NAUT Nautilus Biotechnology, Inc. | 12.13 k | 4.67 k shares | 0.03 | Common equity | Long | USA |
AVIR Atea Pharmaceuticals, Inc. | 12.07 k | 3.14 k shares | 0.03 | Common equity | Long | USA |
ACIU AC Immune SA | 11.88 k | 3.68 k shares | 0.03 | Common equity | Long | Switzerland |
VNDA Vanda Pharmaceuticals Inc. | 11.47 k | 2.17 k shares | 0.03 | Common equity | Long | USA |
EDIT Editas Medicine, Inc. | 11.47 k | 3.07 k shares | 0.03 | Common equity | Long | USA |
QURE uniQure N.V. | 10.60 k | 1.81 k shares | 0.03 | Common equity | Long | Netherlands |
Precigen, Inc.
|
10.34 k | 9.40 k shares | 0.03 | Common equity | Long | USA |
EXAI Exscientia plc | 10.16 k | 1.83 k shares | 0.03 | Common equity | Long | UK |
CABA Cabaletta Bio, Inc. | 10.09 k | 1.79 k shares | 0.03 | Common equity | Long | USA |
BMEA Biomea Fusion, Inc. | 9.84 k | 1.34 k shares | 0.03 | Common equity | Long | USA |
MGTX MeiraGTx Holdings plc | 9.74 k | 2.39 k shares | 0.03 | Common equity | Long | Cayman Islands |